GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (LTS:0Y5E) » Definitions » Total Liabilities

Perrigo Co (LTS:0Y5E) Total Liabilities : $5,852 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Perrigo Co Total Liabilities?

Perrigo Co's Total Liabilities for the quarter that ended in Jun. 2024 was $5,852 Mil.

Perrigo Co's quarterly Total Liabilities declined from Dec. 2023 ($6,041.20 Mil) to Mar. 2024 ($5,953.30 Mil) and declined from Mar. 2024 ($5,953.30 Mil) to Jun. 2024 ($5,852.00 Mil).

Perrigo Co's annual Total Liabilities increased from Dec. 2021 ($5,274.00 Mil) to Dec. 2022 ($6,175.20 Mil) but then declined from Dec. 2022 ($6,175.20 Mil) to Dec. 2023 ($6,041.20 Mil).


Perrigo Co Total Liabilities Historical Data

The historical data trend for Perrigo Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Total Liabilities Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5,497.30 5,833.30 5,274.00 6,175.20 6,041.20

Perrigo Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,116.10 6,020.20 6,041.20 5,953.30 5,852.00

Perrigo Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Perrigo Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1586.3+(3632.8+559.8
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+262.3+0)
=6,041

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=10809.1-4767.9
=6,041

Perrigo Co's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1488.1+(3616.8+535.4
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+211.7+0)
=5,852

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=10397.3-4545.3
=5,852

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Perrigo Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co Headlines

No Headlines